Symbol Name ID |
Lta
lymphotoxin A MGI:104797 |
Darker colors indicate more annotations |
Human Phenotypes | Sinusitis |
Chronic sinusitis |
Keratoconjunctivitis sicca |
Abnormality of the spleen |
Hepatosplenomegaly |
Pancreatitis |
Uveitis |
Recurrent pneumonia |
Autoimmunity |
Asthma |
Nontuberculous mycobacterial pulmonary infection |
Recurrent Burkholderia cepacia infections |
Recurrent Haemophilus influenzae infections |
Recurrent Staphylococcus aureus infections |
Recurrent Aspergillus infections |
Recurrent respiratory infections |
Recurrent bronchopulmonary infections |
Recurrent lower respiratory tract infections |
Disease(s) Associated with LTA | ||||||||||||||||||
asthma | ||||||||||||||||||
cystic fibrosis | ||||||||||||||||||
leprosy | ||||||||||||||||||
neovascular inflammatory vitreoretinopathy | ||||||||||||||||||
Sjogren's syndrome | ||||||||||||||||||
type 1 diabetes mellitus |
Mouse Phenotypes | impaired macrophage phagocytosis |
abnormal thymus epithelium morphology |
abnormal thymus medulla morphology |
small thymus medulla |
insulitis |
periinsulitis |
enlarged spleen |
increased spleen weight |
abnormal lymphopoiesis |
abnormal class switch recombination |
decreased transitional stage B cell number |
increased eosinophil cell number |
increased neutrophil cell number |
abnormal leukocyte cell number |
absent marginal zone B cells |
increased B-1b cell number |
increased B cell number |
decreased NK cell number |
decreased T cell number |
increased lymphocyte cell number |
decreased monocyte cell number |
increased leukocyte cell number |
abnormal lymphocyte morphology |
abnormal gamma-delta T cell morphology |
abnormal spleen morphology |
abnormal spleen white pulp morphology |
decreased spleen B cell follicle number |
absent spleen germinal center |
abnormal spleen marginal zone morphology |
absent spleen marginal zone |
abnormal spleen periarteriolar lymphoid sheath morphology |
decreased spleen white pulp amount |
decreased IgA level |
decreased IgG1 level |
decreased IgG2a level |
decreased IgG3 level |
decreased IgG level |
increased IgM level |
decreased immunoglobulin level |
decreased circulating interferon-gamma level |
abnormal circulating tumor necrosis factor level |
abnormal immune system morphology |
abnormal lymph organ development |
abnormal immune system organ morphology |
absent Peyer's patches |
abnormal lymph node morphology |
absent mesenteric lymph nodes |
abnormal lymph node primary follicle morphology |
absent axillary lymph nodes |
absent brachial lymph nodes |
absent cervical lymph nodes |
absent inguinal lymph nodes |
absent popliteal lymph nodes |
absent peripheral lymph nodes |
absent lymph nodes |
abnormal mucosa-associated lymphoid tissue morphology |
abnormal humoral immune response |
abnormal immune serum protein physiology |
abnormal cytokine secretion |
decreased interferon-gamma secretion |
decreased tumor necrosis factor secretion |
decreased susceptibility to experimental autoimmune encephalomyelitis |
decreased susceptibility to induced arthritis |
decreased susceptibility to endotoxin shock |
liver inflammation |
kidney inflammation |
lung inflammation |
increased susceptibility to bacterial infection |
increased susceptibility to bacterial infection induced morbidity/mortality |
decreased susceptibility to parasitic infection |
increased susceptibility to parasitic infection |
increased susceptibility to Poxviridae infection |
increased susceptibility to Riboviria infection |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lta/Tnftm1Eug/Lta/Tnftm1Eug | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lta/Tnftm1Fda/Lta/Tnftm1Fda | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lta/Tnftm1Jods/Lta/Tnftm1Jods | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltahlb382/Ltahlb382 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltatm1.1(KOMP)Vlcg/Ltatm1.1(KOMP)Vlcg | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltatm1.1Sned/Ltatm1.1Sned | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltatm1Dch/Ltatm1Dch | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltatm1Jods/Ltatm1Jods | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltatm1Tab/Ltatm1Tab | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lta/Tnftm1Fda/Lta+ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Ins2-Lta)#Flv/0 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|